Kanaka Methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 Gene
Inoa mea kūʻai
HWTS-OT077-Human Methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 Gene Detection Kit (Fluorescence PCR)
Palapala
CE
Epidemiology
I ka poe makua, oi aku mamua o 10 8 intestinal epithelial cell e haule mai ka intestinal paia i kela la i keia la, a ua excreted me ka feces ma o ka nui bowel peristalsis.Ma muli o ka hāʻule ʻana o ka ʻōpū o ka ʻōpū o ka hoʻonui ʻia ʻana, ʻo ka ʻōpala o nā mea maʻi maʻi ʻōpū he nui nā maʻi maʻi a me nā ʻāpana cell abnormal, ʻo ia ke kumu kumu no ka ʻike ʻana i ka ʻōpala paʻa.Ua ʻike ʻia nā haʻawina ʻo ka hoʻololi ʻana i ka methylation o nā mea hoʻolaha gene he hanana mua ia i ka tumorigenesis, a ʻo nā mea genetic i loaʻa mai nā kumu hoʻohālike o nā maʻi maʻi maʻi colorectal hiki ke hōʻike i ke ʻano o ka maʻi kanesa i loko o ka ʻōpū ma mua.
ʻO NDRG4, i kapa ʻia ʻo SMAP-8 a me BDM1, ʻo ia kekahi o nā lālā ʻehā o ka ʻohana gene NDRG (NDRG1-4), i hōʻike ʻia e pili ana i ka hoʻonui ʻana o ka cell, ka ʻokoʻa, ka ulu ʻana a me ke kaumaha.Ua hōʻoia ʻia ʻo ka NDRG4 methylation kahi mea biomarker no ka ʻike ʻole ʻana i ka maʻi maʻi colorectal ma nā ʻāpana stool.
He lālā ʻo SEPT9 o ka ʻohana gene Septin, nona ka liʻiliʻi he 13 mau genes e hoʻopili ana i kahi kikowaena GTPase i mālama ʻia e hiki ke hoʻopaʻa i nā protein pili cytoskeleton, a pili pū me ka māhele cell a me ka tumorigenesis.Ua ʻike ʻia nā haʻawina ua hoʻonui nui ʻia ka maʻi methylated Septin9 gene i loko o nā laʻana stool mai nā maʻi me ka maʻi maʻi colorectal.
ʻO nā protein pili i pili i ka frizzled huna (sFRPs) he mau polokina hiki ke hoʻoheheʻe ʻia he papa o nā antagonists ala Wnt ma muli o kā lākou homology kiʻekiʻe i ka mea hoʻokipa frizzled (Fz) no ka hōʻailona Wnt.ʻO ka inactivation o ka SFRP gene ka hopena i ka hoʻōla ʻole ʻia o ka hōʻailona Wnt pili me ka maʻi maʻi colorectal.I kēia manawa, hiki ke hoʻohana ʻia ka SFRP2 methylation i loko o ka stool ma ke ʻano he biomarker non-invasive no ka ʻike ʻana i ka maʻi maʻi colorectal.
He lālā ʻo BMP3 o ka ʻohana super TGF-B a no laila he kuleana koʻikoʻi i ka ulu ʻana o ka embryonic ma o ka hoʻoulu ʻana a me ka hoʻohua ʻana i ka iwi mua.ʻO ka BMP3 ka hypermethylated i ka maʻi maʻi colorectal a hiki ke hoʻohana ʻia ma ke ʻano he hōʻailona koʻikoʻi.
ʻO SDC2 kahi proteoglycan heparan sulfate ma luna o ke kelepona i komo i ka hoʻoponopono ʻana i nā kaʻina hana physiological a me nā pathological.ʻO ke kino i hana ʻia me ka hoʻonui ʻana o ka cell, ka ʻokoʻa, ka adhesion, ka hui cytoskeletal, ka neʻe ʻana, ka hoʻōla ʻana i ka ʻeha, ke kamaʻilio cell-matrix, angiogenesis;ʻO nā kaʻina hana pathological e pili ana i ka mumū a me ke kanesa.ʻOi aku ka kiʻekiʻe o ka pae methylation o ka gene SDC2 i loko o nā ʻiʻo maʻi maʻi colorectal ma mua o nā mea maʻamau.
Kanal
Hoʻopaʻa pānaʻi A | VIC/HEX | methylated NDRG4 gene |
ROX | methylated SEPT9 gene | |
CY5 | hoʻomalu kūloko | |
Paʻa pānaʻi B | VIC/HEX | methylated SFRP2 gene |
ROX | methylated BMP3 gene | |
FAM | methylated SDC2 gene | |
CY5 | hoʻomalu kūloko |
Ka wehewehe
Gene | Kaila hōʻailona | Ct Waiwai | Ka wehewehe |
NDRG4 | VIC (HEX) | Ct waiwai≤38 | NDRG4 maikaʻi |
Waiwai Ct>38 a i ʻole ke kala | NDRG4 maikaʻi ʻole | ||
SEPAT9 | ROX | Ct waiwai≤38 | SEPT9 maikaʻi |
Waiwai Ct>38 a i ʻole ke kala | SEPT9 maikaʻi ʻole | ||
SFRP2 | VIC (HEX) | Ct waiwai≤38 | SFRP2 maikaʻi |
Waiwai Ct>38 a i ʻole ke kala | SFRP2 ʻino |
Nā ʻāpana ʻenehana
Waihona | Ka wai: ≤-18 ℃ |
Kau-ola | 9 mahina |
ʻAno Hoʻohālike | Laʻana Stool |
CV | ≤5.0% |
kikoo | ʻAʻohe ʻano hoʻololi ʻana me ka maʻi maʻi ate, ka maʻi maʻi bile duct, ka maʻi maʻi thyroid a me ka maʻi ʻāʻī |
Nā mea hana pili | QuantStudio ®5 Pūnaehana PCR Manawa maoli SLAN-96P Pūnaehana PCR Manawa maoli LightCycler®480 Pūnaehana PCR manawa maoli LineGene 9600 Plus Pūnaehana ʻike PCR manawa maoli MA-6000 ʻOiaʻiʻo ka nui o ka wela wela |
Holo Hana
Manaʻo ʻia ka hoʻoulu ʻana: Macro & Micro-Test Viral DNA/RNA Kit(HWTS-3001, HWTS-3004-32, HWTS-3004-48, HWTS-3004-96) a me Macro & Micro-Test Automatic Nucleic Acid Extractor(HWTS- 3006).